34
Participants
Start Date
January 7, 2020
Primary Completion Date
February 7, 2022
Study Completion Date
February 7, 2022
Varenicline
All participants will be offered a 13-week course of varenicline (including a 1 week titration period). Dosage and administration per manufacturer: 0.5mg once daily for days 1-3 and 0.5mg twice daily for days 4-7 encompass the titration period, then 1mg twice daily for 12 weeks. An additional 12 weeks of treatment is recommended for long-term abstinence.
Oral Nicotine Replacement Therapy (NRT)
Half of study participants will be randomly assigned to receive oral nicotine replacement therapy (4mg gum or 4mg lozenge, depending on preference; to be used every 1-2 hours as urges occur) in addition to varenicline.
Medication Reminders
Half of study participants will be randomly assigned to receive automated medication reminders via their smartphones.
Tobacco Cessation Counseling
All participants will be offered 6 weekly tobacco cessation counseling sessions with a Tobacco Treatment Specialist.
TSET Health Promotion Research Center, Oklahoma City
Collaborators (1)
Pfizer
INDUSTRY
University of Oklahoma
OTHER